The opinion in support of the decision being entered today was not written for
publication and is not binding precedent of the Board.
Paper No. 43
UNITED STATES PATENT AND TRADEMARK OFFICE
____________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
____________
Ex parte GREGORY R. REYES, DANIEL W. BRADLEY,
JR-SHIN TWU, MICHAEL A. PURDY, ALBERT W. TAM, and
KRZYSZTOF Z. KRAWCZYNSKI
____________
Appeal No. 1997-0473
Application No. 07/870,985
____________
ON BRIEF
____________
Before WILLIAM F. SMITH, ROBINSON, and ADAMS, Administrative Patent Judges
ROBINSON, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. § 134 from the examiner's final
rejection of claims 15 - 18 and 20, which are all of the claims pending in this application.
Claim 15 is illustrative of the claims on appeal and is reproduced below:
15. A method of preventing or treating Hepatitis E Virus (HEV) infection in an
individual, comprising
administering to the individual, by parenteral injection, a vaccine
composition containing antibodies capable of neutralizing HEV infection, as evidenced by
the ability of the composition to block HEV infection of primary human hepatocyte cells in
culture, and where said composition contains an antibody which is immunoreactive with a
peptide containing the C-terminal 48 amino acids of the capsid protein encoded by the
second open reading frame of the HEV genome.
Page: 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007